Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | ATM |
| Variant | Q1970* |
| Impact List | nonsense |
| Protein Effect | loss of function - predicted |
| Gene Variant Descriptions | ATM Q1970* results in a premature truncation of the Atm protein at amino acid 1970 of 3056 (UniProt.org). Q1970* has not been characterized, however, due to the effects of other truncation mutations downstream of Q1970 (PMID: 16603769), is predicted to lead to a loss of Atm protein function. |
| Associated Drug Resistance | |
| Category Variants Paths |
ATM mutant ATM inact mut ATM Q1970* |
| Transcript | NM_000051.4 |
| gDNA | chr11:g.108310305C>T |
| cDNA | c.5908C>T |
| Protein | p.Q1970* |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| XM_017017791.1 | chr11:g.108310305C>T | c.5908C>T | p.Q1970* | RefSeq | GRCh38/hg38 |
| XM_011542843.3 | chr11:g.108310305C>T | c.5908C>T | p.Q1970* | RefSeq | GRCh38/hg38 |
| NM_000051.3 | chr11:g.108310305C>T | c.5908C>T | p.Q1970* | RefSeq | GRCh38/hg38 |
| XM_011542840.4 | chr11:g.108310305C>T | c.5908C>T | p.Q1970* | RefSeq | GRCh38/hg38 |
| XM_005271562.5 | chr11:g.108310305C>T | c.5908C>T | p.Q1970* | RefSeq | GRCh38/hg38 |
| NM_001351834.1 | chr11:g.108310305C>T | c.5908C>T | p.Q1970* | RefSeq | GRCh38/hg38 |
| XM_017017790.3 | chr11:g.108310305C>T | c.5908C>T | p.Q1970* | RefSeq | GRCh38/hg38 |
| NM_001351834.2 | chr11:g.108310305C>T | c.5908C>T | p.Q1970* | RefSeq | GRCh38/hg38 |
| XM_006718843.5 | chr11:g.108310305C>T | c.5908C>T | p.Q1970* | RefSeq | GRCh38/hg38 |
| XM_047426975.1 | chr11:g.108310305C>T | c.5908C>T | p.Q1970* | RefSeq | GRCh38/hg38 |
| XM_047426976.1 | chr11:g.108310305C>T | c.5908C>T | p.Q1970* | RefSeq | GRCh38/hg38 |
| NM_000051.4 | chr11:g.108310305C>T | c.5908C>T | p.Q1970* | RefSeq | GRCh38/hg38 |
| XM_011542840.3 | chr11:g.108310305C>T | c.5908C>T | p.Q1970* | RefSeq | GRCh38/hg38 |
| XM_017017790.2 | chr11:g.108310305C>T | c.5908C>T | p.Q1970* | RefSeq | GRCh38/hg38 |
| XM_017017789.2 | chr11:g.108310305C>T | c.5908C>T | p.Q1970* | RefSeq | GRCh38/hg38 |
| XM_006718843.4 | chr11:g.108310305C>T | c.5908C>T | p.Q1970* | RefSeq | GRCh38/hg38 |
| XM_011542843.2 | chr11:g.108310305C>T | c.5908C>T | p.Q1970* | RefSeq | GRCh38/hg38 |
| XM_005271562.6 | chr11:g.108310305C>T | c.5908C>T | p.Q1970* | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| ATM Q1970* | breast ductal carcinoma | predicted - sensitive | PLX038 + Rucaparib | Case Reports/Case Series | Actionable | In a clinical trial, PLX038 and Rubraca (rucaparib) combination treatment resulted in a complete response within the first treatment cycle, followed by PLX038 monotherapy, which resulted in maintenance of tumor suppression for a total of 12 months in a patient with metastatic breast ductal carcinoma harboring germline ATM Q1970* (PMID: 35999657; NCT04209595). | 35999657 |